CCCC icon

C4 Therapeutics
CCCC

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$8.5
229% upside
High target

4 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wells Fargo
Wells Fargo
Derek Archila
0% 1-yr CCCC win rate
23 Sep ‘25 2 months ago
Barclays
Barclays
Etzer Darout
0% 1-yr CCCC win rate
23 Sep ‘25 2 months ago
Stephens & Co
Stephens & Co
Sudan Loganathan
50% 1-yr CCCC win rate
22 Sep ‘25 2 months ago
Guggenheim
Guggenheim
Bradley Canino
0% 1-yr CCCC win rate
4 Sep ‘25 2 months ago